Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine vs Hydroxyurea in Advanced Proliferative CMML
NCT02214407Phase 3Completed
- Sponsor
- Groupe Français des Myélodysplasies
- Start
- Oct 2014
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in chronic myelomonocytic leukemia (CMML), sponsored by Groupe Français des Myélodysplasies. Started Oct 2014; status: completed.
02
Drugs
decitabine
03
Conditions
chronic myelomonocytic leukemia (CMML)
Beyond the preview
Go deeper on NCT02214407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02214407.